New Chief Fellows 2021-2022
We are pleased to announce that Drs. Karen Axten and Andrew Staron have accepted chief fellow positions for next year. They have big shoes to fill as Raphael and Meredith have done a remarkable job this year — overseeing a curriculum revision, helping support one another through an unprecedented pandemic, and helping with a very […]
Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors
Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors
March 21 Active Clinical Trials
March 2021 Clinical Trials Brochure
February 21 Newsletter
Hem Onc Newsletter-Feb 21
India New England News to honor Dr. Vaishali Sanchorawala as one of their Outstanding Women of the Year Award Recipients
Dr. George Murphy featured in AABB article “Cellular Therapies Fueling New Treatment Options for Hemoglobinopathies”
February 21 Active Clinical Trials
February 2021 Clinical Trials Brochure
January 21 Newsletter
Hem Onc Newsletter-Jan 21
Welcome Khaliun Enkhbayar to the Hagedorn Lab
Please join us in welcoming Khaliun Enkhbayar to the Hagedorn Lab! Khaliun is a junior at Boston University majoring in Biology. For her first two years at BU, she researched how the Piezo2 channel affected the formation of pulmonary neuroendocrine cells (PNECs) in the lung epithelium, in the Rock Lab at the Center for Regenerative […]
Dr. Shuaiying Cui Receives Sickle Cell Disease/Advancing Cures (SCD/AC) Grant Supplement from Doris Duke Charitable Foundation
Congratulations to Dr. Shuaiying Cui who recently received the Sickle Cell Disease/Advancing Cures (SCD/AC) grant supplement from the Doris Duke Charitable Foundation. The purpose of the additional funding totaling $77,000 is to examine the effects of two novel HbF inducers targeting on PGC-1a in human primary hematopoietic progenitor cells.